Molecular DiagnosticsInfectious Disease Testing Market

Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others. Increasing number of infectious diseases and technological advancement in diagnostic technologies for infectious diseases are some major driving factors for molecular diagnostics in the infectious disease testing market. Molecular diagnostics technologies are mainly used to diagnose diseases such as AIDS, tuberculosis (TB), hepatitis, and hospital-acquired infections.

Molecular DiagnosticsInfectious Disease Testing Market contains market size and forecasts of Molecular Diagnostics in Infectious Disease Testing in Global, including the following market information:

• Global Molecular Diagnostics in Infectious Disease Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Molecular Diagnostics in Infectious Disease Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Polymerase Chain Reaction (PCR) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Molecular Diagnostics in Infectious Disease Testing include Abbott, BD, BioMerieux, Thermo Fisher Scientific, Roche, Siemens, Veridex, Luminex and GenMark Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Molecular Diagnostics in Infectious Disease Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Molecular Diagnostics in Infectious Disease Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Molecular Diagnostics in Infectious Disease Testing Market Segment Percentages, by Type, 2021 (%)

• Polymerase Chain Reaction (PCR)
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Microarrays
• Next-Generation Sequencing (NGS)
• Hybridization
• Others

Global Molecular Diagnostics in Infectious Disease Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Molecular Diagnostics in Infectious Disease Testing Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Academic Institutes
• Laboratories
• Others

Global Molecular Diagnostics in Infectious Disease Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Molecular Diagnostics in Infectious Disease Testing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Molecular Diagnostics in Infectious Disease Testing revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Molecular Diagnostics in Infectious Disease Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• BD
• BioMerieux
• Thermo Fisher Scientific
• Roche
• Siemens
• Veridex
• Luminex
• GenMark Diagnostics
• Qiagen
• Genomix Biotech
• BioTheranostics